The Business Times
business-time-50
SUBSCRIBERS

Biopharma firm AbbVie opens S$400m biologics plant in Tuas

The 120,000-sq metre facility, its first manufacturing plant in Asia, will create 250 jobs

google-preferred-sourceAdd BT as a preferred source
Published Wed, Oct 4, 2017 · 09:50 PM

    Singapore

    GLOBAL research and development-based bio-pharmaceutical company AbbVie has enlarged its footprint in Singapore.

    On Wednesday, it opened a new biologics manufacturing plant in Tuas, which will expand its manufacturing capabilities for biologics, which are commercial products derived from biotechnology. (Vaccines are one example.)

    S Iswaran

    TRENDING NOW

    US President Donald Trump with President Xi Jinping after a visit to Zhongnanhai Garden in Beijing, on May 15.

    Xi Jinping has just rewritten the rules of US-China rivalry

    In Malaysia, energy subsidies remain a key challenge for government finances. Yet any reform or reduction must be balanced against rising living costs.

    Growth and stability in the storm: steering Asean economies together

    Always one to walk the talk, DBS CEO Tan Su Shan has her personal AI agent that checks and serves up to her the latest news on banking.

    ‘Even a CEO’s job can be replaced by AI’: DBS CEO Tan Su Shan bets big on agentic AI

    The CSRC is leading the effort, along with the National Financial Regulatory Administration, which handles consumer protection and supervises banks.

    Why China is tightening controls on overseas stock trading

    Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
    Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
    View More